Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

The risk and survival outcome of subsequent primary colorectal cancer after the first primary colorectal cancer: cases from 1973 to 2012

  • Jiao Yang1,
  • Xianglin L. Du2,
  • Shuting Li1,
  • Yinying Wu1,
  • Meng Lv1,
  • Danfeng Dong1,
  • Lingxiao Zhang1,
  • Zheling Chen1,
  • Biyuan Wang1,
  • Fan Wang1,
  • Yanwei Shen1,
  • Enxiao Li1,
  • Min Yi3 and
  • Jin Yang1Email author
BMC Cancer201717:783

https://doi.org/10.1186/s12885-017-3765-8

Received: 19 August 2016

Accepted: 8 November 2017

Published: 22 November 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
19 Aug 2016 Submitted Original manuscript
9 Sep 2016 Author responded Author comments - Jiao Yang
Resubmission - Version 2
9 Sep 2016 Submitted Manuscript version 2
22 Feb 2017 Reviewed Reviewer Report - Rosemary Cress
4 Apr 2017 Reviewed Reviewer Report - Katrina Spilsbury
2 Aug 2017 Author responded Author comments - Jiao Yang
Resubmission - Version 3
2 Aug 2017 Submitted Manuscript version 3
8 Aug 2017 Reviewed Reviewer Report - Rosemary Cress
10 Aug 2017 Reviewed Reviewer Report - Katrina Spilsbury
6 Sep 2017 Author responded Author comments - Jiao Yang
Resubmission - Version 4
6 Sep 2017 Submitted Manuscript version 4
24 Sep 2017 Author responded Author comments - Jiao Yang
Resubmission - Version 5
24 Sep 2017 Submitted Manuscript version 5
Publishing
8 Nov 2017 Editorially accepted
22 Nov 2017 Article published 10.1186/s12885-017-3765-8

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Departments of Medical Oncology, The First Affiliated Hospital of Xi’an Jiaotong University
(2)
Division of Epidemiology & Disease Control, School of Public Health, The University of Texas Health Science Center at Houston
(3)
Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center

Advertisement